Endoscopic vascular targeted photodynamic therapy with the photosensitizer WST11 for benign prostatic hyperplasia in the preclinical dog model.

[1]  S. Chevalier,et al.  Refining the orthotopic dog prostate cancer (DPC)‐1 model to better bridge the gap between rodents and men , 2012, The Prostate.

[2]  G. Skipka,et al.  Systematic review of surgical treatments for benign prostatic hyperplasia and presentation of an approach to investigate therapeutic equivalence (non‐inferiority) , 2012, BJU international.

[3]  A. Scherz,et al.  Preclinical study of the novel vascular occluding agent, WST11, for photodynamic therapy of the canine prostate. , 2011, The Journal of urology.

[4]  Vyacheslav Kalchenko,et al.  Permanent Occlusion of Feeding Arteries and Draining Veins in Solid Mouse Tumors by Vascular Targeted Photodynamic Therapy (VTP) with Tookad , 2010, PloS one.

[5]  N. Northrup,et al.  Prostate cancer in dogs: comparative and clinical aspects. , 2009, Veterinary journal.

[6]  A. Scherz,et al.  Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes. , 2008, Investigative ophthalmology & visual science.

[7]  Eliane Fuseau,et al.  Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling. , 2007, Journal of pharmaceutical sciences.

[8]  Martov Ag,et al.  Photodynamic therapy of prostatic adenoma , 2007 .

[9]  Dwayne J. Dickey,et al.  Interstitial photodynamic therapy of the canine prostate using intra-arterial administration of photosensitizer and computerized pulsed light delivery. , 2007, The Journal of urology.

[10]  M. Elhilali,et al.  Laser treatment of symptomatic benign prostatic hyperplasia , 2006, World Journal of Urology.

[11]  A. Chugh,et al.  Benign prostatic hyperplasia: an insight into current investigational medical therapies , 2005, Expert opinion on investigational drugs.

[12]  A. Scherz,et al.  Novel Water-soluble Bacteriochlorophyll Derivatives for Vascular-targeted Photodynamic Therapy: Synthesis, Solubility, Phototoxicity and the Effect of Serum Proteins¶ , 2005 .

[13]  W. Kassouf,et al.  Expression of vascular endothelial growth factor-A in human lymph node metastases of prostate cancer. , 2004, The Canadian journal of urology.

[14]  Michal Neeman,et al.  Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI , 2003, Nature Medicine.

[15]  Zheng Huang,et al.  Preclinical Studies in Normal Canine Prostate of a Novel Palladium-Bacteriopheophorbide (WST09) Photosensitizer for Photodynamic Therapy of Prostate Cancer¶ , 2002, Photochemistry and photobiology.

[16]  L. Glickman,et al.  Life expectancy, antagonistic pleiotropy, and the testis of dogs and men , 2000, The Prostate.

[17]  D. W. Hayden,et al.  Workgroup 4: Spontaneous prostate carcinoma in dogs and nonhuman primates , 1998, The Prostate.

[18]  L. Glickman,et al.  Comparative longevity of pet dogs and humans: implications for gerontology research. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[19]  D. S. Coffey,et al.  Effects of aging on prostate growth in beagles. , 1986, The American journal of physiology.

[20]  T. Mang,et al.  Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. , 1985, Cancer research.

[21]  C. Roehrborn.  Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). , 2011, The Medical clinics of North America.

[22]  Mark Emberton,et al.  Photodynamic therapy for prostate cancer—a review of current status and future promise , 2009, Nature Clinical Practice Urology.

[23]  Steffen Jung,et al.  Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity , 2008, Cancer Immunology, Immunotherapy.

[24]  D. S. Coffey,et al.  Development of canine benign prostatic hyperplasia with age , 1986, The Prostate.

[25]  S. Ettinger,et al.  Textbook of veterinary internal medicine: Diseases of the dog and cat , 1983 .

[26]  I. Leav,et al.  Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone‐stimulated growth; and the ductal origin of carcinoma , 2022 .